FDA Seeks Input on Use of IT for Clinical Investigations | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

FDA Seeks Input on Use of IT for Clinical Investigations

November 4, 2015
by Heather Landi
| Reprints

The U.S. Food and Drug Administration created a public docket last week to solicit feedback on how healthcare stakeholders are using technology for clinical research in order to improve its clinical investigations.

Announced in the Federal Register, the FDA also seeks stakeholder perspectives on possible barriers to implementing those technologies and methods to conduct clinical investigations.

“Creative uses of technology in conducting clinical investigations have emerged over the previous decade and include advances that have the potential to improve recruitment, participation, and retention of trial participants. New technology and communication infrastructure allow for collection of data and communication wherever the trial participant is located, including at his or her health care provider's location, creating opportunities to overcome geographical and logistical barriers that otherwise might prevent a potential trial participant from participating in a clinical investigation, as well as facilitating the integration of research with clinical care,” the FDA stated.

“Some of these technologies and methods may be used regardless of the trial participant's location and may include, for example, mobile health technology, telemedicine, and remote sensors,” the agency said.

The agency is requesting input in order to identify new opportunities to study medical products, as well as receiving comments on barriers, challenges, and relevant considerations that may affect a medical product clinical investigation that uses these technologies and methods.

The FDA also wants comments on specific issues, such as the technologies, communication infrastructure or innovative methods being used to conduct clinical investigations, ways FDA could encourage adoption of these technologies and innovative methods and the perceived clinical, cultural, business and regulatory barriers that serve as a disincentive to the use of technology to facilitate the conduct of clinical investigations.

The FDA also is interested in stakeholder feedback with regard to trial participants’ interest, concerns and willingness to participate in clinical investigations that involve nontraditional settings or utilize new technologies, such as when data is collected via Bring Your Own Device (BYOD) method.

Electronic or written comments must be submitted by Dec. 28 and can be submitted electronically the Federal eRulemaking Portal.

 

Topics

News

Community Data Sharing: Eight Recommendations From San Diego

A learning guide focuses on San Diego’s experience in building a community health information exchange and the realities of embarking on a broad community collaboration to achieve better data sharing.

HealthlinkNY’s Galanis to Step Down as CEO

Christina Galanis, who has served as president and CEO of HealthlinkNY for the past 13 years, will leave her position at the end of the year.

Email-Related Cyber Attacks a Top Concern for Providers

U.S. healthcare providers overwhelmingly rank email as the top source of a potential data breach, according to new research from email and data security company Mimecast and conducted by HIMSS Analytics.

Former Health IT Head in San Diego County Charged with Defrauding Provider out of $800K

The ex-health IT director at North County Health Services, a San Diego County-based healthcare service provider, has been charged with spearheading fraudulent operations that cost the organization $800,000.

Allscripts Touts 1 Billion API Shares in 2017

Officials from Chicago-based health IT vendor Allscripts have attested that the company has reached a new milestone— one billion application programming interface (API) data exchange transactions in 2017.

Dignity Health, CHI Merging to Form New Catholic Health System

Catholic Health Initiatives (CHI), based in Englewood, Colorado, and San Francisco-based Dignity Health officially announced they are merging and have signed a definitive agreement to combine ministries and create a new, nonprofit Catholic health system.